相关实验视频

Updated: Jun 11, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

通过向CD4747来促进胆管癌的抑制

Kulthida Vaeteewoottacharn¹, Sakda Waraasawapati², Phattarin Pothipan³

¹Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand; Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection and Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-0811, Japan.

Experimental and molecular pathology

|September 28, 2024

概括

在胆管癌 (CCA) 中向分化47 (CD47) 集群的向增强了巨细胞化,并减少了瘤的生长. 通过克服免疫逃避机制,阻止CD47显示出治疗CCA的前景.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

免疫逃避是癌症进展的关键机制,高分化的集群47 (CD47) 保护癌细胞免受细胞分裂.
以前的研究表明,高CD47表达在胆管癌 (CCA) 和抗CD47抗体在CCA去除中的有效性,但机制尚不清楚.
CD47与巨细胞上的信号调节蛋白α (SIRPα) 相互作用,抑制了细胞形成.

研究的目的:

调查向CD47在胆管癌 (CCA) 的临床意义.
阐明CD47抑制影响CCA生长和患者预后的机制.
评估CD47在CCA细胞保护中对巨介导的细胞发生的作用.

主要方法:

免疫组织化学用于确定CCA组织中CD47和CD68的表达,并与临床参数相关联.
为体外和体外研究生成了缺乏CD47的KKU-213A CCA细胞克隆.
使用巨介导的细胞酶定位和瘤异种移植模型来评估CD47的作用.

主要成果:

在CCA组织中的高CD47表达与淋巴结转移有显著的相关性.
在CCA组织中增加的CD68阳性细胞与患者存活率较差有关,并被确定为独立的预后因素.
缺少CD47的CCA克隆在增殖中没有变化,但巨细胞的细胞化增加,并在体内减少瘤生长.

结论:

CD47在胆管癌中发挥着重要作用,通过保护癌细胞免受巨细胞灭菌作用.
向CD47可以增强抗瘤免疫力,并代表了CCA的潜在治疗策略.
CD47表达和巨细胞透是CCA患者的重要预后标志物.

关键词:

胆道癌症是胆道的癌症.CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 胆性瘤是一种胆性瘤.巨细胞是一个巨细胞.单细胞衍生的巨细胞.发细胞症 (phagocytosis) 是一种致死细胞的发生.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...